Parkinson's Disease Analysis

1220 Words3 Pages

Background
Parkinson’s Disease (PD) is a neurodegenerative disease, meaning that it slowly progresses as the brain’s cells lose function or structure (National Parkinson Foundation [NPF], 2014). Parkinson’s disease is a condition affecting movement, also known as a movement disorder (National Library of Medicine [NLM], 2014). Parkinson’s involves the failure and death of the neurons in the brain that control movement and coordination. The neurons that are primarily affected are the substania nigra, which work to release the chemical, dopamine, and to maintain balance and movement (Parkinson’s Disease Foundation [PDF], 2014). There are four main symptoms of PD; tremor or muscle contraction in the extremities or in the face region, including …show more content…

(NPF, 2014). One million people in the world currently suffer from PD (NPF, 2014). Out of all adults age 60 or older, one to two percent currently has this condition (NPF, 2014). People become more prone to obtain this disease as they age. A family history of PD is present in most cases. If there are more than three people affected in a family, specifically if is identified before age 50, researchers believe that a genetic factor may be present (National Human Genome Research Institute [NHGRI], 2014). This gene will make family members more likely to develop the condition (NHGRI, …show more content…

Oxidative stress has been identified as one risk factor that could initiate and/or simulate deterioration of the neurons in the brain (Prasad, Cole & Kumar, 1999). Therefore, taking antioxidants could counteract or slow the progression of the disease (Prasad, Cole & Kumar, 1999). Taking multiple antioxidants, at proper doses, is crucial because multiple types of free radicals can be constructed from each different antioxidant (Prasad, Cole, & Kumar, 1999). Since L-dopa produces free radicals, the grouping of L-dopa with elevated quantities of antioxidants may increase the effectiveness of L-dopa therapy (Prasad, Cole, & Kumar, 1999). Other than this study done by the National Center for Biotechnology Information, there are no other methods known to prevent

More about Parkinson's Disease Analysis

Open Document